Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shilpa Sayana"'
Autor:
Shilpa Sayana, Homayoon Khanlou
Publikováno v:
Future HIV Therapy. 2:125-136
Darunavir (formerly known as TMC 114) is a protease inhibitor that was approved by the US FDA in June 2006 for use in treatment-experienced patients, with markedly greater virological and immunological benefits compared with the standard of care. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40d9d98cd93e6c99a99deba9ffce2870
https://doi.org/10.2217/17469600.2.2.125
https://doi.org/10.2217/17469600.2.2.125
Publikováno v:
Journal of the International Association of Physicians in AIDS Care. 10:135-137
The development of newer agents such as raltegravir, etravirine and maraviroc has improved the perspective of viral load suppression. However, there is not enough data regarding their use together. In this study, we describe nine patients who were tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a766c27974ef3c5fc1046472f0353b
https://doi.org/10.1177/1545109710393311
https://doi.org/10.1177/1545109710393311
Autor:
Homayoon Khanlou, Shilpa Sayana
Publikováno v:
Journal of the International Association of Physicians in AIDS Care. 7:289-291
Meningitis due to methicillin-resistant Staphylococcus aureus is a rare clinical presentation but has been well documented in postneurosurgical patients. To our knowledge, no case of methicillin-resistant Staphylococcus aureus meningitis has been pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666ff5a7fcfacf5b2d6d8ff15dd998ec
https://doi.org/10.1177/1545109708326089
https://doi.org/10.1177/1545109708326089
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 56(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83a388d3d1b1b8e19024dd623c6f600
https://pubmed.ncbi.nlm.nih.gov/22410871
https://pubmed.ncbi.nlm.nih.gov/22410871
Autor:
Shilpa Sayana, Homayoon Khanlou
Publikováno v:
Retrovirology
Retrovirology, Vol 7, Iss Suppl 1, p P48 (2010)
Retrovirology, Vol 7, Iss Suppl 1, p P48 (2010)
Background Although the durability of antiretroviral (ARV) efficacy has improved, mainly due to better tolerability, ease of administration (adherence) and potency, some patients still encounter virological and immunological treatment failure. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b44d09e6f3f420c5eb4c266f8c2716
https://doi.org/10.1186/1742-4690-7-s1-p48
https://doi.org/10.1186/1742-4690-7-s1-p48
Autor:
Shilpa Sayana, Rishi Manchanda, Michael Weinstein, Jorge Saavedra, Homayoon Khanlou, Peter Reis
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 53(1)
This letter to the editor discusses the results of a Development of Antiretroviral Therapy in Africa (DART) study which found that little survival benefit was attained with laboratory monitoring as opposed to clinical monitoring alone in the care of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89eeb7b6820df6aa5cc2beaa213b9f27
https://pubmed.ncbi.nlm.nih.gov/20035167
https://pubmed.ncbi.nlm.nih.gov/20035167
Autor:
Shilpa Sayana, Homayoon Khanlou
Publikováno v:
Expert review of anti-infective therapy. 7(1)
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into the cell requires binding to a CD4 molecule and, in the majority of cases,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562b412ec583313788f183fb76e6db0b
https://pubmed.ncbi.nlm.nih.gov/19622053
https://pubmed.ncbi.nlm.nih.gov/19622053
Autor:
Homayoon Khanlou, Shilpa Sayana
Publikováno v:
Expert review of anti-infective therapy. 6(4)
Raltegravir (formerly known as MK-0518; Isentress) is the first in a new class of integrase inhibitors approved for the use in treatment-experienced adult patients who have evidence of viral replication and HIV strains resistant to multiple antiretro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754b926a67173117d1ee4119c132f95c
https://pubmed.ncbi.nlm.nih.gov/18662108
https://pubmed.ncbi.nlm.nih.gov/18662108
Publikováno v:
Clinical Infectious Diseases. 51:868-869
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed37ae9b9effef19fb679fce08ff5a04
https://doi.org/10.1086/656291
https://doi.org/10.1086/656291
Publikováno v:
The American Journal of the Medical Sciences. 339:290-291
Pyogenic liver abscesses are rarely encountered in HIV-infected patients living outside of temperate climates and are usually polymicrobial in nature, with a majority of the pathogens arising from gastrointestinal flora. We describe the second case o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9ee778b09f2ba57126cd7ba6a43961
https://doi.org/10.1097/maj.0b013e3181c6ef05
https://doi.org/10.1097/maj.0b013e3181c6ef05